Cargando…
S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN)
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428507/ http://dx.doi.org/10.1097/01.HS9.0000967984.54376.db |
| _version_ | 1785090486703226880 |
|---|---|
| author | Anderson, Alan El Rassi, Fuad Debaun, Michael R. Idowu, Modupe Kanter, Julie Adam, Soheir Curtis, Susanna Liles, Darla Andemariam, Biree Mclemore, Morgan L. Sheppard Nickel, Robert Ramadas, Poornima Paulose, Jincy Laine, Dram Khan, Mahmudul Darbari, Deepika Burnett, Arthur L. |
| author_facet | Anderson, Alan El Rassi, Fuad Debaun, Michael R. Idowu, Modupe Kanter, Julie Adam, Soheir Curtis, Susanna Liles, Darla Andemariam, Biree Mclemore, Morgan L. Sheppard Nickel, Robert Ramadas, Poornima Paulose, Jincy Laine, Dram Khan, Mahmudul Darbari, Deepika Burnett, Arthur L. |
| author_sort | Anderson, Alan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428507 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104285072023-08-17 S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN) Anderson, Alan El Rassi, Fuad Debaun, Michael R. Idowu, Modupe Kanter, Julie Adam, Soheir Curtis, Susanna Liles, Darla Andemariam, Biree Mclemore, Morgan L. Sheppard Nickel, Robert Ramadas, Poornima Paulose, Jincy Laine, Dram Khan, Mahmudul Darbari, Deepika Burnett, Arthur L. Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428507/ http://dx.doi.org/10.1097/01.HS9.0000967984.54376.db Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Anderson, Alan El Rassi, Fuad Debaun, Michael R. Idowu, Modupe Kanter, Julie Adam, Soheir Curtis, Susanna Liles, Darla Andemariam, Biree Mclemore, Morgan L. Sheppard Nickel, Robert Ramadas, Poornima Paulose, Jincy Laine, Dram Khan, Mahmudul Darbari, Deepika Burnett, Arthur L. S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN) |
| title | S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN) |
| title_full | S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN) |
| title_fullStr | S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN) |
| title_full_unstemmed | S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN) |
| title_short | S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN) |
| title_sort | s268: interim analysis of a phase 2 trial to assess the efficacy and safety of crizanlizumab in sickle cell disease patients with priapism (spartan) |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428507/ http://dx.doi.org/10.1097/01.HS9.0000967984.54376.db |
| work_keys_str_mv | AT andersonalan s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT elrassifuad s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT debaunmichaelr s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT idowumodupe s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT kanterjulie s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT adamsoheir s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT curtissusanna s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT lilesdarla s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT andemariambiree s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT mclemoremorganl s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT sheppardnickelrobert s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT ramadaspoornima s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT paulosejincy s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT lainedram s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT khanmahmudul s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT darbarideepika s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan AT burnettarthurl s268interimanalysisofaphase2trialtoassesstheefficacyandsafetyofcrizanlizumabinsicklecelldiseasepatientswithpriapismspartan |